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ABSTRACT
Background: Patent Ductus Arteriosus (PDA) is a common cardiac malformation whose 
treatment locally has been surgical ligation via a lateral thoracotomy. Device closure of 
the ductus was first performed at the Mater hospital in 1999 in a ten year old male using 
a five millilitre detachable cook coil. In 2000 the Amplatzer device was introduced to 
close larger ducts. Subsequently these devices have been used interchangeably to close 
both small and large ducts. We report this single centre experience of percutaneous 
PDA closure in a resource-limited setting; utilising the two techniques. 
Objective: To describe our experience of trans-catheter closure of small and large 
ducts using either the detachable Cook coils or the Amplatzer occluders at the Mater 
Hospital Nairobi. 
Design: A descriptive retrospective cohort study.
Setting: The Mater Hospital, Nairobi, Kenya.
Subjects: Patients with clinical and echo-cardiographic features of patent ductus 
arteriosus who underwent cardiac catheterisation and angiography followed by device 
embolisation of the ductus.
Results: From April 1999 to October 2009 a total of ninety eight subjects were recruited 
into the study. Sixty nine (70%) of these subjects had the ducts closed using the 
Amplatzer devices, while twenty nine (30%) were embolised using the cook detachable 
coils. Three of the subjects in the coil group had the ducts embolised using the double 
technique while the rest were embolised using single coils. Various coil sizes four 
to eight millimetres were used in patients with small to medium ducts (two to seven 
millimetres) whereas the Amplatzer duct occluder was successfully used in all the 
duct sizes. The Amplatzer atrial septal occluder device was used to close very large 
ducts in two of the patients. The overall success rate was 93.1%, but the coil group had 
higher failure rate of 6.9% compared to the Amplatzer group of 3%. One patient in the 
Amplatzer group had a late embolisation requiring surgical retrieval at one month 
post occlusion. There were no mortalities.
Conclusion: Transcatheter device occlusion of PDA is a safe and alternative to 
surgery associated with minimal 
morbidity and no mortality
INTRODUCTION
Patent ductus arteriosus (PDA) is a common 
congenital heart disease occurring in 1:2000 neonates 
delivered at term. As an isolated malformation 
it accounts for 10 to 18% of all cardiovascular 
malformations and is more common in females. Left 
untreated PDA can be complicated by failure to thrive, 
recurrent chest infections, cardiac enlargement and 
failure, bacterial endocarditis and endarteritis (1) and 
sadly in this environment irreversible pulmonary 
hypertension due to late presentation. A diagnosis of 
PDA therefore constitutes an indication for treatment. 
Locally, treatment of PDA has been surgical ligation 
through a lateral thoracotomy. This simple surgical 
procedure can be complicated by bleeding, recurrent 
laryngeal nerve palsy, thoracic duct damage and 
chylothorax and in some instances recanalisation of 
the ductus (1).
 The cardiac catheterisation unit of the Mater 
hospital was established in 1995. In April 1999 a ten 
year male child with recurrent recanalised ductus 
from two previous surgical ligations had successful 
embolisation of his ductus using a 5 mm detachable 
cook coil. The same year in august, five more patients 
with small ducts were successfully closed using 
detachable cook coils. The Amplatzer device was 
first used in the unit in 2000 initially for closing 
larger ducts of 5mm and more.  Later the use 
was extended to close smaller ducts of 3 to 5 mm, 
however with time due to the erratic local supply 
and the expense, the multiple coils were used to close 
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larger ducts either through the arterial route or a 
combination of trans-venous and trans-arterial routes. 
We hereby report our single institution experience of 
the complementary use of either type of devices to 
close small and larger ducts at the Mater hospital.
 MATERIALS AND METHODS
This was a descriptive retrospective cohort study 
conducted from 1999-2009. Patients with clinical 
and echo-cardiographic features of patent ductus 
arteriosus who underwent cardiac catheterisation and 
angiography followed by device embolisation of the 
ductus were selected. The diagnosis of PDA was based 
on characteristic clinical and echo-cardiographic 
features. Selection for cardiac catheterisation was 
not randomised but depended on size of the duct at 
echocardiography and the size of device available 
in the cardiac laboratory at the time of diagnosis. 
During cardiac catheterisation deep sedation was 
given to infants and children up to 12 years while 
local anaesthesia and conscious sedation was given 
to older children and adults. Intra-venous Cefuroxime 
was used for anti-biotic prophylaxis in all the patients 
and intra-venous heparin at 100 units/kg body 
weight was given once vascular access was obtained. 
After catheterisation, angiography was performed to 
confirm the echo-cardiographic findings followed by 
device embolisation using either the cook coils or 
Amplatzer devices. The extracted included patients 
baseline parameters of age, sex, weight and height, 
echo-cardiographic parameters including size of 
ductus, pulmonary pressures, catheterisation data 
including size and type of device , technique of 
embolisation, outcomes and complications of the 
procedure. After the initial learning curve from a 
constant visiting interventional cardiologist the 
procedures were performed by the same local doctors 
except for double coil embolisation. Premature 
babies, patients with very large ducts and those with 
clinical and echo-cardiographic evidence of severe 
pulmonary hypertension including Eisenmenger 
physiology were excluded from the study.  Ethical 
clearance was obtained from the hospitals standard 
and ethics committee
Techniques of implantation: The coil group; Two 
techniques were used to close the PDA using coils, 
the single coil technique and the double coil technique
Single coil Technique: The single coil method was 
performed retrograde through femoral artery 
using 5 or 6f introducer sheath. An aortogram was 
performed in the lateral- lateral position to profile 
and measure the size of the PDA for purpose the 
appropriate size of coil (Figure 1A). A Judkins 
right coronary 5 or 6F was used to enter duct from 
the descending aorta .A suitable coil, connected to 
delivery wire was then inserted into catheter and 
advanced into pulmonary artery. The mandil was 
then withdrawn to produce loop in the duct, then the 
catheter withdrawn to extrude coil in ductal ampulla 
(Figure 1B). The coil was then detached   and post 
delivery angiograms were performed (Figure 1C). The 
final position was confirmed in the antero-posterior 
view (Figure 1D) .Post procedure chest X-ray and 
echo-cardiogram performed before releasing the 
patient to the High dependency unit for monitoring.
Figure 1 (A-D)
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Figure 1A aortogram in the lateral view to profile 
the ductus B coil loop extruded in the ductus,C an 
aortogram to confirm the occlusion and D a chest 
radiograph showing the coil in the ductus.
Double coil technique: Instances when an aortogram 
showed a larger duct, the double coil procedure was 
chosen. In technique of implantation both antegrade 
cannulation of the ductus from the femoral vein and 
retrograde from the femoral artery was used to cross 
the duct as shown in Figures 2.  After profiling the 
ductus (Figure 2A), it was crossed both from the 
inferior venacava and the descending aorta (Figure 
2B). The aortic coil was first mounted (Figure 2C) 
followed by the coil from the pulmonary artery 
(Figure 2D), then both coils released. A final aortogram 
was performed in the lateral position confirming 
complete occlusion (Figure 2E) before an antero-
posterior radiogram to show the final position of 
the coil (Figure 2F)
Figure 2A-2G 
Showing the antegrade and retrograde techniques for 
double coil occlusion for smaller to moderate size ducts
           
2A
Large duct profiled using an aortogram in lateral 
position.
2B
Both catheters in the ductus with dual entry from the 
right and left heart
2C
Antegrade coil mounted into duct.
2D
Both in the ductus before release.
2E
An aortogram in lateral-lateral position showing 
complete occlusion of the ductus
2F
Final appearance of the coil in  plain chest radiograph
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Technique implantation Amplatzer device: This technique 
involves right and left heart cannulation from the 
right femoral vessels. After profiling the ductus via 
an aortogram in the lateral-lateral position (Figure 
3A), a right coronary catheter was used to cross the 
ductus from the venous side into the descending aorta 
where it was exchanged for long guide wire (Figure 
3B).  A long sheath Mullins was then passed over 
guide wire into the descending aorta and the inner 
shaft removed. The device was then loaded into the 
delivery system and mounted into the Mullins sheath 
in the descending aorta .Together these were drawn 
into the ductus using the tracheal bifurcation as a 
guide (Figure 3C). Pre deployment aortogram was 
performed to assess the extent of occlusion before 
(Figure 3D) and a post deployment radiograph to 
document the final position of the device made 
(Figure 3E)
 Figure 3
Serial photographs showing techniques of duct 
embolisation using the Amplatzer duct occlude device
   
3A
Initial aortogram profiling the ductus
3B
Exchange guide wire crossing the ductus into the 
descending aorta
3C
Device mounted into the delivery system  in the 
descending aorta.
3D
An aortogram in the lateral-lateral position before 
release of the device showing complete occlusion.
3E
The final position of the device on a chest radiogram.
RESULTS
Of the 103 patients who underwent diagnostic 
catherisation five patients were excluded from 
embolisation. Of these, two had very tiny ducts and 
no further interventions were offered while three 
had very large ducts and were sent for surgical 
ligation. The remaining 98 patients underwent duct 
embolisation using either a coil or Amplatzer device. 
218 East african MEdical Journal July 2013 
Twenty nine (29.6%) had their ducts embolised by 
the coils while 69(70.4%) were embolised using the 
Amplatzer devices. The overall mean age was six 
years with a range of two months to 22 years and a 
female preponderance of 2:1. Most infants(age less 
than one year)  had their ducts embolised using the 
Amplatzer device, 14.5% compared to only 3%of 
coils used. However with advancing age of ten and 
above both devices were used in similar proportions 
(Figure 4).
Figure 4
Age category versus the type of device used (N = 98)  
Comparatively, patients who had their ducts 
embolised using the coils had a higher mean weight 
and age (30 kg and 7.8 years) compared to the 
Amplatzer group (19 and 5.9 years) five patients (5%) 
were suffering from congenital Rubella.  The overall 
success rate of 93% with a slightly higher rate in the 
Amplatzer group 97% compared to the coil group 
of 93% (Table 1).
Table 1
Profiles of patients undergoing Amplatzer and coil embolisation
Amplatzer Coil 
No. of Patients 69 29
Patients below one year  10(14.5%)  2(3%)
Mean Age( yrs)  5.9 7.8 
Male: Female 1:2 1:3
Mean Weight 19.15kgs 30.8kgs
Mean Height 107 cms 102 cms
Mean PDA size 8mm 5mm
Congenital rubella 2(3%) 3(10.3%)
Complete Occlusion 64(92.8%) 27(93.1%)
Residual shunts 2(3%) 1(3.4%)
Failed /abandoned 3(4.5%) 1(3.4%)
Coil group (total 29): Although this group were 
of a mean older age, they had no clinical, echo-
cardiographic and catheterisation evidence of 
pulmonary hypertension. There was a history of 
recanalised ducts from previous surgery in three 
patients, congenital rubella in another three and 
small ventricular septal defects in two patients. Two 
of the patients had failed embolisation from another 
institution. The majority 22 (75.6%) had the ducts 
embolised using 5 mm coil, while three (10.3%) had 
8 mm coil, and one (0.3%) using a 4 mm coil. The 
double coils (Figures 2) were used in three patients 
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two sets of 5 mm coils  and one set of 5 mm and 4 mm 
coil (Figure 5). All three patients had total occlusion 
of their ducts. In two patients there was embolisation 
of the coil to the distal left pulmonary artery branch 
but both were successfully retrieved with subsequent 
placement of a bigger size 8 coil while the other was 
closed using an Amplatzer device. There was residual 
shunting seen in 3.4% of the subjects. While in one 
with a small ductus were totally failed occlude the 
duct despite numerous attempts. This was one of the 
patients with congenital Rubella syndrome
Figure 5
Number of patients against the size of coils (n=29) 
The Amplatzer group (total 69): This group included a 
wide variety of duct sizes ranging from small 3mm to 
very large ducts of 12 mm.   One patient had an atypical 
ductus connecting the right pulmonary artery to the 
right brachiocephalic trunk. Moderate pulmonary 
hypertension was encountered in one patient, while 
two had congenital rubella syndrome. Additional 
findings included one patient with pulmonary valve 
stenosis associated with moderate size ductus.  Two 
cases in this group had very large ducts requiring 
larger devices so we used 20 mm Amplatzer ASD 
occluder device (Figure 6), of these  one  had full 
occlusion  while the other failed and was  taken for 
surgical ligation.
 Figure 6
Number of patients Vs size of Amplatzer device (n=66)
 
Follow-up and complications:  Follow-up echo 
cardiograms were done at discharge, then at intervals 
of one three and six months. Majority of the patients 
were discharged from follow-up after two years but 
some who had additional lesions like congenital 
Rubella, ventricular septal defects and pulmonary 
valve stenosis have been followed for longer periods 
up to ten years.  There was one late embolisation into 
the iliac bifurcation after three month in a four year 
old female embolised using size 8/6 of the Amplatzer 
group. She underwent surgical retrieval of the device. 
There was no echo-cardiographic evidence of left 
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pulmonary stenosis on follow-up. The younger 
patients less than two years who had larger ducts 
had their devices protruding   into the lumen of the 
descending aorta but no coarctation of aorta was 
noted on follow-up.  Persistent resting bradycardia 
was noted one patient (coil) group immediately post 
embolisation which resolved within six months of 
follow-up. No case of infective endocarditis was 
observed although two patients developed rheumatic 
heart disease, mild aortic and mitral regurgitation in 
one while the other had mild mitral regurgitation. 
Both were in the Amplatzer group.
DISCUSSION
The PDA remains a common congenital heart disease. 
As an isolated lesion it forms about five to ten percent 
of all congenital cardiac diseases. Prior to 1999 all 
cases diagnosed with PDA locally were treated with 
surgical ligation through a thoracotomy irrespective 
of age of the patient or size and shape of the PDA. 
Although thoracotomy is a relatively safe procedure, 
it requires extended hospital stay and convalescence. 
Some complications have been encountered including 
bleeding, atelectasis and lung collapse, damage 
to recurrent laryngeal nerves, chylothorax and 
occasionally death. Recanalisations have also been 
a frequent observation.  In April 1999 a ten year old 
male who underwent thoracotomy twice and still had 
significant residual shunting of a recanalised ductus 
underwent successful percutaneous embolisation 
of the duct using a 5 mm detachable cook coil. This 
excitement led to further closure of five more patients 
three of which had previous surgery and recanalised 
ducts. This experience was presented to the Kenya 
cardiac society annual scientific conference in 2000 
(2). Further experience into the year was still limited 
to smaller ducts but in august 2000 the Amplatzer 
duct occluder was introduced into the unit making 
it possible to close larger ducts.  Irrespective of the 
duct size we are now able to interchange the coils and 
the Amplatzer devices in a complimentary manner. 
 Transcatheter closure of PDA was first described 
by Portsman et al, (3) and thereafter several devices 
and techniques have been described and perfected. 
These include the Rashkind’s double umbrella 
technique (3), the Sideris button device (4), Cooks 
detachable coils (5) and most recently the Amplatzer 
duct occluder (6). 
 Although patients in the coil groups were older 
(mean age of eight years) none had pulmonary 
hypertension due to a smaller PDA size averaging 
5 mm. The rational for selecting this treatment 
modality was because the procedure was found 
less cumbersome. The presence of additional 
lesions small Ventricular septal defects in three of 
the twenty six patients did not affect the outcome 
of the procedure and no concomitant intervention 
was offered  apart from advising on antibiotic 
prophylaxis for infective endocarditis during dental 
and surgical procedures. A total of five patients who 
had congenital Rubella and small ducts were treated, 
two with the Amplatzer device and three with coil 
embolisation. Complete occlusion was achieved in 
four of the five patients while the remaining patient 
failed to totally occlude the duct with the coil. 
Patent ductus arteriosus is commonly associated 
with congenital rubella occurring in 50% of cases. 
Local encounter of PDA and congenital Rubella has 
been that of large ducts associated with pulmonary 
hypertension and treatment has been surgical ligation. 
However, Bergum in Bangladesh reported two cases 
of congenital rubella with large PDA successfully 
occluded with the Lifetech PDA occluder device (11).
Our cases were small ducts of 5 mm and less.
 The double coil technique (Figures 2) was used 
for larger ductus, at a time when we had run out 
of the Amplatzer device in the unit. None of these 
patients had residual shunting on follow-up. We 
also did not find any branch pulmonary stenosis 
especially the left pulmonary artery. During the initial 
experience our tutor deliberately embolised the coil 
into the left pulmonary and taught us how to retrieve 
it, with this tutorship any coil which embolised to 
the pulmonary tree was successfully retrieved and 
repositioned and non in this group required surgical 
intervention. Although the technique for the coil 
embolisation was that of controlled release when 
the duct ampulla allowed, some coil was implanted 
without the delivery system 
 The Amplatzer group was a much younger 
and lighter population with a mean weight of 19 kg 
compared to the coil group of 30 kg and had a higher 
occlusion rate. Despite the fact that this method of 
embolisation was learnt later after the coil the learning 
cue was very short only two weeks and we had a 
higher occlusion rates. The duct sizes were variable 
from very small to very large ducts with 65% of 
patients having moderate size duct hence the use 
of 8/6 and 10/8 devices , an  experience described 
by others ( 8,9,10). Only one patient had moderate 
pulmonary hypertension the rest had basically normal 
pulmonary pressures. Subsequent follow-up of the 
pulmonary pressures at six months and two years 
showed regression of the pressures to mild pulmonary 
hypertension. Pulmonary hypertension is considered 
a contraindication to Amplatzer device embolisation. 
We did not use these devices in patients with severe 
pulmonary hypertension.
 There was a higher rate of residual shunting in the 
coil group (3.4%) compared to the Amplatzer group 
of 1.5% (Table1). One would have used additional 
coils to completely eliminate the shunts however 
no further treatment was offered due to limited 
choices of the coils and devices. Bacterial endocarditis 
and haemolysis are known complications of these 
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procedures (12). We did not observe any of these 
during the brief and long term follow up. However 
in this environment endo-cardial involvement 
from rheumatic fever is common and two patients 
developed rheumatic heart disease during the follow 
up period. They have been retained on long term 
follow-up for purposes of disease prophylaxis and 
monitoring for any risk of long term infective endo-
carditis.  The mean duration of hospitalisation was 
one day for older patients and two days for younger 
patients and those who had general anaesthesia. This 
did not differ between the types of devices used.
 Our main challenges were the patients who 
had very large ducts at angiography which at echo-
cardiographic selection were of moderate size. In two 
of these patients the 20 mm Amplatzer ASD occluder 
devices were used. One had complete occlusion but 
the other had significant residual shunting.  When 
comparing the techniques of occlusion the coil patients 
and the Amplatzer patients the coil group had a longer 
learning curve than the Amplatzer group. The cost 
of coil devices is four to five times cheaper than the 
Amplatzer devices and this would be a reasonable 
option to close the ducts especially in resource scarce 
settings.
Study limitations: The selection of patients was 
dependent on echo-cardiographic assessment to 
match the device available in stock however selection 
of the size and type of device was determined by the 
angio-graphy of the duct. This led to the exclusion of 
patients after undergoing angio-graphy due to lack 
of appropriate devices. 
In conclusion, complementary transcatheter use of 
Amplatzer duct occluders and detachable cook coils 
for closure of ducts feasible even in resource scarce 
settings and is a safe alternative to surgery. The use 
of multiple coils is feasible in patients with small to 
larger ducts, whereas, the Amplatzer devices can be 
successfully used in all the duct sizes.  
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